BrainsWay Ltd.
BWAY
Rank in Stocks
#12482
Established in Jerusalem, Israel, in 2003, BrainsWay Ltd. specializes globally... Established in Jerusalem, Israel, in 2003, BrainsWay Ltd. specializes globally in creating and distributing advanced, non-invasive neurostimulation therapies designed to address a wide array of mental health and neurological conditions. The company's primary innovation is its Deep Transcranial Magnetic Stimulation (dTMS) platform, which offers treatment for disorders including major and anxious depression, obsessive-compulsive disorder, nicotine addiction, bipolar disorder, post-traumatic stress disorder, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's solutions are primarily adopted by psychiatric practitioners, hospitals, and medical centers across the United States, Europe, Israel, and other international markets.
Share Price
$11.64
Last synced: 2026-11-09
Market Cap
$465.51M
Change (1 day)
4.39%
Change (1 year)
53.36%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BrainsWay Ltd. (BWAY)
Category
Healthcare
Operating Margin for BrainsWay Ltd. (BWAY)
Operating Margin as of November 2026 TTM: 12.18%
According to BrainsWay Ltd.'s latest financial reports, its current operating margin (TTM) is 12.18%. At the end of 2025 the company had an operating margin of 8.28%.
Operating Margin history for BrainsWay Ltd. from 2012 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 12.18% | 47.10% |
| 2025 | 8.28% | 144.25% |
| 2024 | 3.39% | -121.73% |
| 2023 | -15.60% | -66.57% |
| 2022 | -46.67% | 176.81% |
| 2021 | -16.86% | -22.98% |
| 2020 | -21.89% | -40.34% |
| 2019 | -36.69% | 17.63% |
| 2018 | -31.19% | -47.42% |
| 2017 | -59.32% | 230.47% |
| 2016 | -17.95% | -72.91% |
| 2015 | -66.25% | -69.23% |
| 2014 | -215.30% | -40.01% |
| 2013 | -358.87% | -77.00% |
| 2012 | -1,560.22% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 18.91% | -98.45% |
IE
|
|
| 10.95% | -99.10% |
CN
|
|
| 25.26% | -97.93% |
CH
|
|
| 13.54% | -98.89% |
CH
|
|
| 38.62% | -96.83% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about BrainsWay Ltd.'s operating margin
What is BrainsWay Ltd.'s operating margin?
BrainsWay Ltd.'s operating margin is 12.18%, as of Nov 2026.
What was BrainsWay Ltd.'s operating margin in 2025?
In 2025, BrainsWay Ltd.'s operating margin was 8.28%, compared with 3.39% in 2024.
How has BrainsWay Ltd.'s operating margin changed since 2020?
From 2020 to 2025, BrainsWay Ltd.'s operating margin was highest in 2025 (8.28%) and lowest in 2022 (-46.67%).
How does BrainsWay Ltd.'s operating margin compare with similar companies?
BrainsWay Ltd.'s operating margin (12.18%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Jafron Biomedical Co.,Ltd., with 38.62%.